|
ATCC
ovarian cancer cell line Ovarian Cancer Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+eoc+cell+line+sk-ov-3/SK-OV-3/pmc03408041-37-7-25 Average 99 stars, based on 1 article reviews
ovarian cancer cell line - by Bioz Stars,
2026-09
99/100 stars
|
Buy from Supplier |
|
iCell Bioscience Inc
human serous ovarian cancer skov3 cell line Human Serous Ovarian Cancer Skov3 Cell Line, supplied by iCell Bioscience Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+eoc+cell+line+sk-ov-3/skov3/pm34268111-72-2-12 Average 90 stars, based on 1 article reviews
human serous ovarian cancer skov3 cell line - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
National Centre for Cell Science
caco-2 human colorectal adenocarcinoma cells Caco 2 Human Colorectal Adenocarcinoma Cells, supplied by National Centre for Cell Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+eoc+cell+line+sk-ov-3/hct+116/pmc08159990-159-6-44 Average 90 stars, based on 1 article reviews
caco-2 human colorectal adenocarcinoma cells - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
Johns Hopkins HealthCare
human ovarian carcinoma cell lines a2780 Human Ovarian Carcinoma Cell Lines A2780, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+eoc+cell+line+sk-ov-3/ovarian+cancer+cell+lines+a2780/10__1158_slash_0008___5472__can___20___4243-65-0-20 Average 90 stars, based on 1 article reviews
human ovarian carcinoma cell lines a2780 - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
ATCC
human cell lines Human Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+eoc+cell+line+sk-ov-3/MCF7/pm12802284-204-1-30 Average 99 stars, based on 1 article reviews
human cell lines - by Bioz Stars,
2026-09
99/100 stars
|
Buy from Supplier |
|
ATCC
human tumor cell lines Human Tumor Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+eoc+cell+line+sk-ov-3/A549/pmc03134670-181-0-24 Average 99 stars, based on 1 article reviews
human tumor cell lines - by Bioz Stars,
2026-09
99/100 stars
|
Buy from Supplier |
|
ATCC
high grade human ovarian cancer cells ![]() High Grade Human Ovarian Cancer Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+eoc+cell+line+sk-ov-3/TOV-112D/pmc08124100-42-0-13 Average 96 stars, based on 1 article reviews
high grade human ovarian cancer cells - by Bioz Stars,
2026-09
96/100 stars
|
Buy from Supplier |
|
ATCC
human ovarian serous adenocarcinoma cell lines skov3 ![]() Human Ovarian Serous Adenocarcinoma Cell Lines Skov3, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+eoc+cell+line+sk-ov-3/SK-OV-3%3B+Ovarian+Adenocarcinoma%3B+Human/pm37759323-40-0-7 Average 96 stars, based on 1 article reviews
human ovarian serous adenocarcinoma cell lines skov3 - by Bioz Stars,
2026-09
96/100 stars
|
Buy from Supplier |
|
European Collection of Authenticated Cell Cultures
human ovary adenocarcinoma sk-ov-3 cell line no. 91091004 ![]() Human Ovary Adenocarcinoma Sk Ov 3 Cell Line No. 91091004, supplied by European Collection of Authenticated Cell Cultures, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+eoc+cell+line+sk-ov-3/skov+3/pmc08143583-166-9-39 Average 90 stars, based on 1 article reviews
human ovary adenocarcinoma sk-ov-3 cell line no. 91091004 - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
HFK Bioscience
gfp-lc3b-skov3 cells ![]() Gfp Lc3b Skov3 Cells, supplied by HFK Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+eoc+cell+line+sk-ov-3/skov3+cells/pm25893854-229-0-14 Average 90 stars, based on 1 article reviews
gfp-lc3b-skov3 cells - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
China Center for Type Culture Collection
human ovarian cancer cell lines sk-ov-3 and ho-8910 ![]() Human Ovarian Cancer Cell Lines Sk Ov 3 And Ho 8910, supplied by China Center for Type Culture Collection, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+eoc+cell+line+sk-ov-3/skov3/10__3390_slash_molecules17032704-67-2-25 Average 90 stars, based on 1 article reviews
human ovarian cancer cell lines sk-ov-3 and ho-8910 - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
CEM Corporation
sk-ov-3 ![]() Sk Ov 3, supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+eoc+cell+line+sk-ov-3/sk+ov+3/pm23537165-71-9-3 Average 90 stars, based on 1 article reviews
sk-ov-3 - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Cancer Medicine
Article Title: ONC201 induces the unfolded protein response (UPR) in high‐ and low‐grade ovarian carcinoma cell lines and leads to cell death regardless of platinum sensitivity
doi: 10.1002/cam4.3858
Figure Lengend Snippet: ONC201 inhibits viability of OVCA cells. (A and B) ONC201 reduces cell viability of SKOV3, OV433, CaOV3, TOV112D, VOA4627, and VOA1312 cells in a dose and time‐dependent manner. Cells were treated with either vehicle or drug at the indicated concentration (0/1/10/25/50/100/200 µM) for (A) 48 h and (B) 72 h MTT assay results are shown. The absorbance was read at 540 nm using an automated microplate reader. The percentage of cell viability was calculated to compare the vehicle group. Data were expressed as the percent cell proliferation relative to the control as mean ± SD from triplicate wells. (C) ONC201 inhibits OVCA migration. Cells were treated by ONC201 (0/1/10/100 µM) and migration of cells was evaluated via wound healing assay. Cells were seeded and left overnight. The following day a “wound” was created using 200 µl pipet tips and treated with ONC201. After incubation with ONC201 for 8–24 h depending on the cell line, cells were washed by DPBS and were stained with crystal violet. Dose‐dependent decreased cell migration was noted in all cell lines. A representative image from three independent experiments is shown (image magnification ×200). A p ‐value ≤0.05 is presented as * and p ≤ 0.01 as **
Article Snippet:
Techniques: Concentration Assay, MTT Assay, Control, Migration, Wound Healing Assay, Incubation, Staining
Journal: Cancer Medicine
Article Title: ONC201 induces the unfolded protein response (UPR) in high‐ and low‐grade ovarian carcinoma cell lines and leads to cell death regardless of platinum sensitivity
doi: 10.1002/cam4.3858
Figure Lengend Snippet: ONC201 downregulates PI3K/AKT and ERK/MEK signaling pathway. ONC201 (20 µM) inhibits AKT and ERK in high‐ and low‐grade OVCA cells. Lysates were collected from SKOV3 and VOA4627 cell lines at 48, 72, and 96 h and western blot was completed with indicated antibodies. A p ‐value ≤0.05 is presented as * and p ≤ 0.01 as **
Article Snippet:
Techniques: Western Blot
Journal: Cancer Medicine
Article Title: ONC201 induces the unfolded protein response (UPR) in high‐ and low‐grade ovarian carcinoma cell lines and leads to cell death regardless of platinum sensitivity
doi: 10.1002/cam4.3858
Figure Lengend Snippet: ONC201 activates ER stress. The expression of UPR‐related genes was evaluated by qPCR in SKOV3 (A), VOA1312 (B), OV433 (C), and CaOV3 (D). CHOP expression was induced 5–15 fold in all cell lines, suggesting that ONC201 prompts ER stress in human OVCA cells. (E) ONC201 (20 µM) upregulated protein expression of CHOP and ATF4. A p ‐value ≤0.05 is presented as * and p ≤ 0.01 as **
Article Snippet:
Techniques: Expressing
Journal: Cancer Medicine
Article Title: ONC201 induces the unfolded protein response (UPR) in high‐ and low‐grade ovarian carcinoma cell lines and leads to cell death regardless of platinum sensitivity
doi: 10.1002/cam4.3858
Figure Lengend Snippet: ONC201 promotes apoptosis both in high‐ and low‐grade OVCA cells. (A) SKOV3 and VOA4627 cells treated with or without ONC201 (20 µM) were double‐stained with Annexin V and PI, and then analyzed by flow cytometry. The percentages of viable cells (compared to vehicle) are shown. (B) Representative flow diagram of Annexin V‐PI staining. (C) Caspase3/7 activity was measured by Caspase‐Glo 3/7 assay. SKOV3 and VOA4627 cells were treated with ONC201 (20 µM) for 48, 72 h. Caspase3/7 activity was increased from 48 to 72 h. (D) ONC201‐treated lysates were collected from SKOV3 and VOA4627 cell lines and blotted with Wee1 antibodies. A p ‐value ≤0.05 is presented as * and p ≤ 0.01 as **
Article Snippet:
Techniques: Staining, Flow Cytometry, Activity Assay, Caspase-Glo Assay
Journal: Cancer Medicine
Article Title: ONC201 induces the unfolded protein response (UPR) in high‐ and low‐grade ovarian carcinoma cell lines and leads to cell death regardless of platinum sensitivity
doi: 10.1002/cam4.3858
Figure Lengend Snippet: ONC201 leads cells to intrinsic rather than TRAIL‐induced cell death. (A) ONC201 leads to a loss of mitochondrial membrane potential (MMP). MMP was measured by JC‐1 assay. JC‐1 monomers (green) were increased by ONC201 (20 µM) treatment over time both in SKOV3 and VOA4627 cells. (B) After treating with ONC201 (20 µM) for 48 and 72 h, cells are harvested and cell extracts were analyzed by western blotting to detect the expression of cleaved PARP, BIM, and Mcl‐1. (C and D) ONC201 (20 µM) led OVCA cells to death via TRAIL‐independent pathway. Lysates were collected from SKOV3 and VOA4627 cell lines and blotted with TRAIL antibodies. Whereas, the expression of DR5 gene was confirmed by qPCR in SKOV3, OV433, CaOV3, and VOA1312. (E) ONC201 does not activate Caspase‐8. Caspase‐8 (p18/p10) was found intact both in ONC201 treated and control SKOV3 cells. A p ‐value ≤0.05 is presented as * and p ≤ 0.01 as **
Article Snippet:
Techniques: Membrane, Western Blot, Expressing, Control
Journal: Cancer Medicine
Article Title: ONC201 induces the unfolded protein response (UPR) in high‐ and low‐grade ovarian carcinoma cell lines and leads to cell death regardless of platinum sensitivity
doi: 10.1002/cam4.3858
Figure Lengend Snippet: ONC201 increases endoplasmic reticulum stress in both high‐grade and low‐grade ovarian cancer cells; overwhelming pro‐survival signals and activating the pro‐death arm of the unfolded protein response pathway. In addition, a weekly oral dose of ONC201 lowers the tumor burden in mice. This is a promising therapeutic agent in OVCA treatment and should be considered for clinical translation
Article Snippet:
Techniques:
Journal: Cell & bioscience
Article Title: MRE11:p.K464R mutation mediates olaparib resistance by enhancing DNA damage repair in HGSOC.
doi: 10.1186/s13578-023-01117-0
Figure Lengend Snippet: Fig. 3 MRE11:p.K464R mutation leads to Olaparib resistance in ovarian cancer cells. (A-B) The stable cell lines of SKOV3 (A) and A2780-MRE11WT/MRE11K464R (B) were constructed expressing MRE11WT and MRE11K464R protein and detected the MRE11 protein expression with West ern blot. (C-D) SKOV3 (C) and A2780 (D) MRE11WT /MRE11K464R cells were treated for 96 h with indicated dose of Olaparib and viability assessed by CCK8. (E-F) Representative pictures of colony formation assay in SKOV3 (E) and A2780 (F) MRE11WT /MRE11K464R cells treated with or without Olaparib for 10 days are in left. Relative colony formation rates of cell are presented as percent relative to DMSO (right). (G-H) SKOV3 (G) and A2780 (H) MRE11WT/MRE11K464R cells were treated with or without Olaparib for 48 h and then stained for γH2AX, MRE11, and DAPI (left), and quantified the γH2AX foci per cell (right). Scale bar, 25 μm. (I-J) SKOV3 (I) and A2780 (J) MRE11WT/ MRE11K464R cells were treated with or without Olaparib for 48 h and subjected to Comet analysis. DNA damage is quantified as percent DNA in tails. Each group represents at least 100 cells counted. Data are presented as mean values ± SEM from three independent experiments. ***p < 0.001, ****p < 0.0001, ns, not significant, as determined by the unpaired two-tailed Student’s t-test
Article Snippet:
Techniques: Mutagenesis, Stable Transfection, Construct, Expressing, Colony Assay, Staining, Two Tailed Test
Journal: Cell & bioscience
Article Title: MRE11:p.K464R mutation mediates olaparib resistance by enhancing DNA damage repair in HGSOC.
doi: 10.1186/s13578-023-01117-0
Figure Lengend Snippet: Fig. 4 Interactions of MRE11:p.K464R with RAD50/RPS3. (A) Schematic diagram of IP-MS detection. (B) The directly-interacting proteins of MRE11 were screened in the String database according to the IP-MS data. (C-D) SKOV3- MRE11WT/MRE11K464R cells were treated with or without Olaparib for 24 h. The cells were then lysed and immunoprecipitation with MRE11 antibody (C) and the relative gray scale density of RAD50(up) and RPS3 (down) to MRE11 are presented in D.(E-F) SKOV3- MRE11WT/MRE11K464R cells were treated with Olaparib or DMSO. The cells were then lysed and immunoprecipitation with RPS3 antibody (E) and the relative gray scale density of RAD50 (up) and MRE11 (down) to MRE11 are presented in F. (G-H) Detection of MRE11-RAD50 (G) and MRE11-RPS3(H) interaction was carried out by PLA labeling in SKOV3 MRE11WT/MRE11K464R cells treated with or without Olaparib for 24 h. Rep resentative images are shown. Scale bars, 5 μm. The scatterplot displays quantification of the PLA signals per nucleus from at least 100 cells from three independent experiments. Data are mean ± SEM. (I-J) ER-AsiSI Hela cells were transfected with empty vector or MRE11WT or MRE11K464R, and then treated with 4-OHT to induce DSBs. RAD50 (I) and RPS3 (J) accumulation at DNA damage sites generated by AsiSI was detected by ChIP qPCR. Data are presented as mean values ± SEM from three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, ns, not significant, as determined by the unpaired two-tailed Student’s t-test
Article Snippet:
Techniques: Protein-Protein interactions, Immunoprecipitation, Labeling, Transfection, Plasmid Preparation, Generated, ChIP-qPCR, Two Tailed Test
Journal: Cell & bioscience
Article Title: MRE11:p.K464R mutation mediates olaparib resistance by enhancing DNA damage repair in HGSOC.
doi: 10.1186/s13578-023-01117-0
Figure Lengend Snippet: Fig. 5 Effects of MRE11_K464R mutation on NHEJ pathway. (A) Expression of NHEJ key proteins in SKOV3 MRE11WT /MRE11K464R cells after treated with Olaparib for 48 h, detected by Western Blot with indicated antibodies. (B) MRE11WT or MRE11K464R virus were infected into EJ5-Hela cells for 24 h. Then, the cells were transfected with an I-SceI expression plasmid for 48 h. NHEJ efficiency were determined by FACS. (C) ER-AsiSI Hela cells were infected with MRE11WT or MRE11K464R virus, and then treated with 4-OHT to induce DSBs. Ku70 accumulation at DNA damage sites generated by AsiSI was detect ed by ChIP qPCR. (D) A2780 MRE11WT /MRE11K464R cells after treated with Olaparib for 48 h. The chromatin fractions and the soluble nuclear fractions were analyzed with indicated antibodies by Western Blot. (E-F) A2780 MRE11WT /MRE11K464R cells were treated with or with Olaparib for 48 h, and co-stained with Ku70 (green) and γH2AX (red) antibodies. E The representative images of immunofluorescence are presented, F quantification of Ku70 and γH2AX co-localization ratio per cell. Each group represents at least 100 cells counted. Scale bar, 10 μm. (G) MRE11_K464R with or without siNC/siRAD50/siRPS3 were infected into EJ5-Hela cells for 24 h. Then, the cells were transfected with an I-SceI expression plasmid for 48 h. NHEJ efficiency were determined by FACS. (H) MRE11_K464R with or without siNC/siRAD50/siRPS3 were infected into ER-AsiSI Hela cells and then treated with 4-OHT to induce DSBs. Ku70 accumulation at DNA damage sites generated by AsiSI was detected by ChIP qPCR. (I) SKOV3 (left) and A2780 (right) MRE11K464R cells were treated for 96 h with indicated doses of Olaparib or SCR7 (up) / AZD7648 (down) alone or combined for 96 h and viability assessed. Data are presented as mean values ± SEM from three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, ns, not significant, as determined by the unpaired two-tailed Student’s t-test
Article Snippet:
Techniques: Mutagenesis, Expressing, Western Blot, Virus, Infection, Transfection, Plasmid Preparation, Generated, ChIP-qPCR, Staining, Immunofluorescence, Two Tailed Test
Journal: Cell & bioscience
Article Title: MRE11:p.K464R mutation mediates olaparib resistance by enhancing DNA damage repair in HGSOC.
doi: 10.1186/s13578-023-01117-0
Figure Lengend Snippet: Fig. 6 RPS3/RAD50 knockdown sensitizes K464R mutant cells to Olaparib. (A-B) SKOV3 (A) and A2780 (B) MRE11K464R cells were transfected with siRAD50 or siRPS3 alone or combine for 24 h and then treated for 96 h with indicated doses of Olaparib and viability was measured by CCK8. The expres sion of scramble siRNA (siNC) was used as control. (C-D) Cells were transfected with siRAD50 or siRPS3 alone or combine for 24 h and then treated with or without Olaparib for 10 days. The expression of siNC was used as control. Representative pictures of clonogenic assay in A2780 MRE11K464R cells (C). The mean clones of ROI are presented (D). (E-F) SKOV3 (E) and A2780 (F) MRE11K464R cells were transfected with siRAD50 or siRPS3 alone or combine for 24 h and then treated for 48 h and then subjected to Comet analysis. DNA damage is quantified as percent DNA in tails. The expression of siNC was used as control. Each group represents at least 150 cells counted. (G-H) SKOV3 (G) and A2780(H) MRE11K464R cells were transfected with siRAD50 or siRPS3 alone or combine for 24 h and then treated with or without Olaparib for 48 h and then stained for γH2AX (green) and DAPI (blue), and γH2AX foci-positive cells were quantified (below). Each group represents at least 150 cells counted. Scale bar, 20 μm. Data are presented as mean values ± SEM from three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, ns, not significant, as determined by the unpaired two-tailed Student’s t-test
Article Snippet:
Techniques: Knockdown, Mutagenesis, Transfection, Control, Expressing, Clonogenic Assay, Clone Assay, Staining, Two Tailed Test